128 related articles for article (PubMed ID: 23633236)
41. Next-generation sequencing in the evaluation of biliary strictures in patients with primary sclerosing cholangitis.
Scheid JF; Rosenbaum MW; Przybyszewski EM; Krishnan K; Forcione DG; Iafrate AJ; Staller KD; Misdraji J; Lennerz JK; Pitman MB; Pratt DS
Cancer Cytopathol; 2022 Mar; 130(3):215-230. PubMed ID: 34726838
[TBL] [Abstract][Full Text] [Related]
42. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y
Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685
[TBL] [Abstract][Full Text] [Related]
43. Modern diagnostic approaches to cholangiocarcinoma.
Vasilieva LE; Papadhimitriou SI; Dourakis SP
Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):349-59. PubMed ID: 22893461
[TBL] [Abstract][Full Text] [Related]
44. An extended fluorescence in situ hybridization approach for the cytogenetic study of cholangiocarcinoma on endoscopic retrograde cholangiopancreatography brushing cytology preparations.
Vasilieva LE; Papadhimitriou SI; Alexopoulou A; Pavlidis D; Kostopoulos I; Georgiakaki M; Xinopoulos D; Romanos A; Dourakis SP
Hum Pathol; 2013 Oct; 44(10):2173-9. PubMed ID: 23845469
[TBL] [Abstract][Full Text] [Related]
45. Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: the Papanicolaou Society of Cytopathology guidelines for pancreatobiliary cytology.
Layfield LJ; Ehya H; Filie AC; Hruban RH; Jhala N; Joseph L; Vielh P; Pitman MB;
Diagn Cytopathol; 2014 Apr; 42(4):351-62. PubMed ID: 24639398
[TBL] [Abstract][Full Text] [Related]
46. Evaluating the Significance of Pancreatobiliary Fluorescence In Situ Hybridization Polysomy on Prognosis in De Novo Cholangiocarcinoma.
Ji H; Barr Fritcher EG; Yin J; Bainter TM; Zemla TJ; Gores GJ; Halling KC; Kipp BR; Roberts LR
Clin Transl Gastroenterol; 2022 Oct; 13(10):e00523. PubMed ID: 36000989
[TBL] [Abstract][Full Text] [Related]
47. Preliminary experience comparing routine cytology results with the composite results of digital image analysis and fluorescence in situ hybridization in patients undergoing EUS-guided FNA.
Levy MJ; Clain JE; Clayton A; Halling KC; Kipp BR; Rajan E; Roberts LR; Root RM; Sebo TJ; Topazian MD; Wang KK; Wiersema MJ; Gores GJ
Gastrointest Endosc; 2007 Sep; 66(3):483-90. PubMed ID: 17725938
[TBL] [Abstract][Full Text] [Related]
48. An animal model of benign bile-duct stricture, sclerosing cholangitis and cholangiocarcinoma and the role of epidermal growth factor receptor in ductal proliferation.
Cheifetz RE; Davis NL; Owen DA
Can J Surg; 1996 Jun; 39(3):193-7. PubMed ID: 8640617
[TBL] [Abstract][Full Text] [Related]
49. Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis.
Bangarulingam SY; Bjornsson E; Enders F; Barr Fritcher EG; Gores G; Halling KC; Lindor KD
Hepatology; 2010 Jan; 51(1):174-80. PubMed ID: 19877179
[TBL] [Abstract][Full Text] [Related]
50. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN
Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310
[TBL] [Abstract][Full Text] [Related]
51. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
[TBL] [Abstract][Full Text] [Related]
52. Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer.
Feldmann G; Nattermann J; Nischalke HD; Gorschlüter M; Kuntzen T; Ahlenstiel G; Gerhardt T; Wolff M; Sauerbruch T; Spengler U; Dumoulin FL
Endoscopy; 2006 Jun; 38(6):604-9. PubMed ID: 16673309
[TBL] [Abstract][Full Text] [Related]
53. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis: A better FISH to detect pancreatobiliary cancer?
Patman G
Nat Rev Gastroenterol Hepatol; 2015 Oct; 12(10):551. PubMed ID: 26369313
[No Abstract] [Full Text] [Related]
55. Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology.
Baskin-Bey ES; Moreno Luna LE; Gores GJ
J Hepatol; 2006 Oct; 45(4):476-9. PubMed ID: 16901574
[No Abstract] [Full Text] [Related]
56. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases.
Layfield LJ; Cramer H
Diagn Cytopathol; 2005 Feb; 32(2):119-24. PubMed ID: 15637668
[TBL] [Abstract][Full Text] [Related]
57. Establishment and characterization of a human cholangiocarcinoma cell line.
Ma S; Hu L; Huang XH; Cao LQ; Chan KW; Wang Q; Guan XY
Oncol Rep; 2007 Nov; 18(5):1195-200. PubMed ID: 17914572
[TBL] [Abstract][Full Text] [Related]
58. Brush cytology of the biliary tract: retrospective study of 278 cases with histopathologic correlation.
Govil H; Reddy V; Kluskens L; Treaba D; Massarani-Wafai R; Selvaggi S; Gattuso P
Diagn Cytopathol; 2002 May; 26(5):273-7. PubMed ID: 11992366
[TBL] [Abstract][Full Text] [Related]
59. Multimodal data analysis reveals that pancreatobiliary-type ampullary adenocarcinoma resembles pancreatic adenocarcinoma and differs from cholangiocarcinoma.
Cheng J; Mao Y; Hong W; Hu W; Shu P; Huang K; Yu J; Jiang M; Li L; Wang W; Ni D; Li S
J Transl Med; 2022 Jun; 20(1):272. PubMed ID: 35705951
[TBL] [Abstract][Full Text] [Related]
60. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
